Early blood rise in auto-antibodies to nuclear and smooth muscle antigens is predictive of prolonged survival and autoimmunity in metastatic-non-small cell lung cancer patients treated with PD-1 immune-check point blockade by nivolumab. - Giannicola, Rocco; D'Arrigo, Graziella; Botta, Cirino; Agostino, Rita; Del Medico, Pietro; Falzea, Antonia Consuelo; Barbieri, Vito; Staropoli, Nicoletta; Del Giudice, Teresa; Pastina, Pierpaolo; Nardone, Valerio; Monoriti, Marika; et al. (Molecular & Clinical Oncology, 2019)